Jinhe Biotechnology CO., LTD. (SHE:002688)
4.850
-0.120 (-2.41%)
Jun 11, 2026, 1:25 PM CST
SHE:002688 Revenue
Jinhe Biotechnology CO., LTD. had revenue of 741.88M CNY in the quarter ending March 31, 2026, with 18.67% growth. This brings the company's revenue in the last twelve months to 2.99B, up 20.94% year-over-year. In the year 2025, Jinhe Biotechnology CO., LTD. had annual revenue of 2.88B with 21.41% growth.
Revenue (ttm)
2.99B
Revenue Growth
+20.94%
P/S Ratio
1.24
Revenue / Employee
1.10M
Employees
2,476
Market Cap
3.73B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.88B | 507.47M | 21.41% |
| Dec 31, 2024 | 2.37B | 196.50M | 9.04% |
| Dec 31, 2023 | 2.17B | 51.43M | 2.42% |
| Jan 1, 2023 | 2.12B | 44.72M | 2.15% |
| Jan 1, 2022 | 2.08B | 263.35M | 14.51% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jinling Pharmaceutical Company | 3.16B |
| Bide Pharmatech | 1.35B |
| Tibet Weixinkang Medicine | 1.16B |
| LanZhou Foci Pharmaceutical | 910.98M |
| Nanjing Hicin Pharmaceutical | 688.74M |
| Newland Pharmaceutical | 659.54M |
| Shanghai Xiao Fang Pharmaceutical | 541.90M |
| Hubei Biocause Heilen Pharmaceutical | 459.02M |